Explain the associated pathophysiologic and lifestyle risks for adults with metabolic syndrome for the development of cardiovascular, renal, and hepatic diseases.
Discuss new and emerging pharmacologic therapies for the management of complications of metabolic disease.
Recommend a treatment plan for patients who present with cardiorenal metabolic disease.